Becton's $200 Mil. Clontech Buy Broadens Life Science Research Offerings
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson's $200 mil. acquisition of molecular biology research products maker Clontech Labs will significantly broaden the BD Biosciences life science research product line, according to the company.